• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination., An Issue of Clinics in Liver Disease

Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination., An Issue of Clinics in Liver Disease

9780323939478
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
438.43 zł
372.67 zł Save 65.76 zł Tax included
Lowest price within 30 days before promotion: 372.67 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Clinics in Liver Disease, guest editor Robert G. Gish brings his considerable expertise to the topic of Hepatitis B and Hepatitis D. The articles provide state-of-the-art clinical summaries of the advances in Hepatitis B and D, with emphasis on HBV viro-immunology, novel assays, new targets, and tests for HBV and HDV, and more.
Product Details
Elsevier
99448
9780323939478
9780323939478

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
240
Weight (g)
450
  • Chronic Hepatitis B: Treat all Who Are Viremic?
    Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?
    What Is the Current Status of Hepatitis B Virus Viro-Immunology?
    Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
    Overview of New Targets for Hepatitis B Virus: Immune Modulators, Interferons, Bifunctional Peptides, Therapeutic Vaccines and Beyond
    Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers
    Targeting Hepatitis B Virus DNA Using Designer Gene Editors
    Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus
    State of the Art: Test all for Anti-Hepatitis D Virus and Reflex to Hepatitis D Virus RNA Polymerase Chain Reaction Quantification
    Triple Threat: HDV, HBV, HIV Coinfection
    What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?
    What is the Path Forward to Treat Hepatitis Delta Virus?: Old Treatments and New Options
    Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible
Comments (0)